Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

31.77
Delayed Data
As of Jan 20
 +0.07 / +0.22%
Today’s Change
28.25
Today|||52-Week Range
37.39
-2.19%
Year-to-Date
How Will Pfizer Inc. Fare Under President Trump?
12:12pm / MotleyFool.com - Paid Partner Content
Teva's (TEVA) Pain Drug Vantrela ER Receives FDA Approval
Jan 19 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Gilead Sciences, Las Vegas Sands, Illinois Tool Wo...
Jan 20 / Zacks.com - Paid Partner Content
Lilly to Boost Migraine Pipeline with $960M CoLucid Buyout
Jan 19 / Zacks.com - Paid Partner Content
Are You Undervaluing These 3 Biopharmas' Pipelines?
Jan 20 / MotleyFool.com - Paid Partner Content
5 Most Important Drugs to Johnson & Johnson in 2017
Jan 18 / MotleyFool.com - Paid Partner Content
Top Analyst Reports for Gilead Sciences, Las Vegas Sands & Illinois Tool Works
Jan 19 / Zacks.com - Paid Partner Content
5 Expensive Drugs That Could End Up in Trump's Crosshairs
Jan 18 / MotleyFool.com - Paid Partner Content
Fcm Investments Buys Paycom Software Inc, Alibaba Group Holding Ltd, Enterprise Produ...
Jan 19 / GuruFocus News - Paid Partner Content
What???s Ahead for Johnson & Johnson (JNJ) in Q4 Earnings?
Jan 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close31.70
Today’s open31.72
Day’s range31.66 - 32.12
Volume30,159,695
Average volume (3 months)24,886,288
Market cap$192.8B
Dividend yield4.03%
Data as of 4:01pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+9.99%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)-1.52%
P/E ratio31.8
Price/Sales4.13
Price/Book3.03

Competitors

 Today’s
change
Today’s
% change
MRKMerck+2.20+3.65%
NVSNovartis+0.22+0.31%
SNYSanofi+0.18+0.45%
ABBVAbbVie-0.23-0.37%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$0.51
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts


Search for Jobs